Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of NF1 mRNA | decreases expression | 20406850
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of NF1 mRNA | increases expression | 16788091
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of NF1 mRNA | affects expression | 17331233
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NF1 mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NF1 mRNA | decreases expression | 19150397
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of NF1 mRNA | decreases expression | 18007998
|
D004958 |
Estradiol |
Estradiol results in increased expression of NF1 mRNA | increases expression | 19429434
|
D005473 |
Fluoxetine |
Fluoxetine results in decreased expression of NF1 mRNA | decreases expression | 17105902
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NF1 mRNA | affects cotreatment|increases expression | 17183730
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of NF1 mRNA | increases expression | 15674843
|
D010269 |
Paraquat |
Paraquat affects the expression of NF1 mRNA | affects expression | 15206577
|
D020849 |
Raloxifene |
Raloxifene results in increased expression of NF1 mRNA | increases expression | 19429434
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of NF1 mRNA | increases expression | 20308225
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of NF1 mRNA | decreases expression | 18175754
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NF1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.54 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.30 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.30 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.67 | 6695378 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.76 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.96 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.81 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.63 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.55 | 15800139 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.30 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Fluoxetine |
9.40 | 18083778 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
9.40 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.72 | 10378619 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 15389774 |
MESH:D001321 |
Autistic Disorder |
|
Fluoxetine |
2.57 | 19232924 18775368 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.57 | 18177632 20603192 17157402 18316065 18558336 15238991 18396377 17507914 18940202 18985861 18775368 19232924 17688650 19460635 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.09 | 20046352 17594078 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.21 | 19167455 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.42 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.89 | 11985600 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.52 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.98 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.98 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.98 | 14630087 17289903 12948864 19861407 18497071 17018787 17261762 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
1.98 | 17440819 15775269 16912660 17049068 15758505 17242785 15572757 17261762 17893378 16837676 17952589 17595753 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.21 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
5.04 | 17687719 10378619 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.51 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.61 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.61 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.61 | 17306315 15276417 16507464 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.04 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.62 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.62 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.10 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.46 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
16.19 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.19 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
16.19 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
16.19 | 20056578 19524636 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.79 | 15894690 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.66 | 15800139 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.89 | 8888407 17688650 16575769 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.06 | 18551238 |
MESH:D003866 |
Depressive Disorder |
|
Fluoxetine |
4.62 | 15014590 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.19 | 17474826 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.80 | 16285004 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.09 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.09 | 17308373 17451421 15920148 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.34 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.34 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.34 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.08 | 1851702 |
MESH:D004487 |
Edema |
|
Fluoxetine |
11.98 | 12798668 |
MESH:D004487 |
Edema |
|
Mustard Gas |
11.98 | 11428647 11428631 9260866 11402378 |
MESH:D004487 |
Edema |
|
Raloxifene |
11.98 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
4.03 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.00 | 11473722 19148513 18566989 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.19 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.98 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.95 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.61 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.34 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.11 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.21 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.37 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.37 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.14 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.14 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.95 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.17 | 8888407 18558336 |
MESH:D005354 |
Fibrosarcoma |
marker/mechanism |
|
| 20601955 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.73 | 16452187 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.23 | 11124998 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.67 | 20471113 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.55 | 11110106 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.09 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.18 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
10.75 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Fluoxetine |
10.75 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.92 | 17688650 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.87 | 17577099 15787275 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.67 | 16612254 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
6.98 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.98 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Fluoxetine |
5.83 | 12798668 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
5.83 | 11428631 11428620 11428647 9357497 11402378 17524151 16001271 8975870 9260866 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
12.51 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
12.51 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
12.51 | 14714311 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.16 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.16 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.44 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.44 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.53 | 16973256 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
marker/mechanism |
|
| 21441929 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.15 | 16294345 17596541 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
marker/mechanism |
|
| |
MESH:D008064 |
Lipidoses |
|
Fluoxetine |
4.67 | 17567588 15342952 |
MESH:D008080 |
Liposarcoma |
marker/mechanism |
|
| 20601955 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.68 | 14716833 14659978 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.50 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.50 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.50 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.56 | 2876786 2876784 6135515 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
7.60 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.60 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.32 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.06 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.50 | 18520028 20064080 20464547 20135361 18569708 17053015 6695378 20869020 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
3.50 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.50 | 17077188 16712894 15276417 17306315 19931552 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.09 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.58 | 16891317 11807958 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.55 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.03 | 16487513 19082730 |
MESH:D001523 |
Mental Disorders |
|
Fluoxetine |
4.68 | 16856516 |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 21236316 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.19 | 16966607 18303189 16166281 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.21 | 18803445 18765137 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.62 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.46 | 16497877 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.06 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.17 | 17596541 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.30 | 16810080 |
MESH:D009207 |
Myoclonus |
|
Fluoxetine |
5.93 | 8041377 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.62 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.91 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.07 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.07 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.71 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.78 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.74 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.87 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.87 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.40 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.40 | 16359493 8888407 |
MESH:D009456 |
Neurofibromatosis 1 |
marker/mechanism |
|
| |
OMIM:162210 |
NEUROFIBROMATOSIS, FAMILIAL SPINAL |
marker/mechanism |
|
| |
MESH:C537393 |
Neurofibromatosis-Noonan syndrome |
marker/mechanism |
|
| |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
4.00 | 16761898 7688884 |
MESH:D009771 |
Obsessive-Compulsive Disorder |
|
Fluoxetine |
5.47 | 20418887 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.46 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.41 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.26 | 17823083 15758505 15579764 17893378 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.04 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.86 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.86 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Fluoxetine |
4.36 | 12798668 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.82 | 11445065 11124998 16140633 16510128 15451049 11181820 12911755 15824117 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.47 | 16190885 |
MESH:D020774 |
Pick Disease of the Brain |
|
Fluoxetine |
6.04 | 8041377 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.93 | 10923243 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.50 | 12504350 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.83 | 15727166 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.91 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.91 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.65 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.65 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.89 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.89 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
1.89 | 18760546 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
4.14 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.60 | 12752131 11422049 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.84 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
9.43 | 17975199 15814490 17322281 17365031 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
9.43 | 17620002 17894541 10334151 17266442 17720292 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
9.43 | 17997886 16324872 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.62 | 15770314 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.94 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
4.10 | 11874814 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.89 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.21 | 19155313 |
MESH:D012509 |
Sarcoma |
marker/mechanism |
|
| 20601955 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.00 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.00 | 14763951 16876388 17978042 3137016 11044598 1511512 15475178 11738929 |
MESH:D020230 |
Serotonin Syndrome |
|
Fluoxetine |
5.96 | 8704074 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.72 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.75 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.75 | 18572023 19524636 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.61 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.61 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.60 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.84 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.03 | 16045194 16684133 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.92 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.92 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.30 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.57 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.03 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
12.03 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
12.03 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.03 | 17306315 16452187 16712894 11723127 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.68 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.37 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.79 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.07 | 14652134 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.47 | 17056641 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.27 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.62 | 16343187 |
OMIM:193520 |
WATSON SYNDROME |
marker/mechanism |
|
| |